Michael J. Yang's Net Worth
$2.95 Million
Who is Michael J. Yang?
Michael J. Yang has an estimated net worth of $2.95 Million. This is based on reported shares across multiple companies, which include ACADIA PHARMACEUTICALS INC, AKCEA THERAPEUTICS, INC., Pacira BioSciences, Inc., and IONIS PHARMACEUTICALS INC.
SEC CIK
Michael J. Yang's CIK is 0001702283
Past Insider Trading and Trends
2019 was Michael J. Yang's most active year for acquiring shares with 8 total transactions. Michael J. Yang's most active month to acquire stocks was the month of March. 2019 was Michael J. Yang's most active year for disposing of shares, totalling 10 transactions. Michael J. Yang's most active month to dispose stocks was the month of November. 2019 saw Michael J. Yang paying a total of $3,800,100.00 for 251,369 shares, this is the most they've acquired in one year. In 2019 Michael J. Yang cashed out on 243,377 shares for a total of $5,456,828.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
EVP and CCO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.81% | 1.6K |
$53.34 | -$59,740.80 | 8.06K |
Jan 6
| |||
Form 4
| +24.08% | 1.25K |
$42.56 | -$53,072.32 | 6.46K |
Oct 15 - Oct 16
| |||
Form 4
|
—
|
0
|
$39.63 | -$906,016.36 | 5.2K |
Scheduled
|
Jul 7
| ||
Form 4
| +108.24% | 2.71K |
$49.21 | -$73,864.21 | 5.2K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
$37.78 | -$1,409,885.95 | 2.5K |
Scheduled
|
Dec 12
| ||
Form 4
|
—
|
0
|
$43.16 | -$212,069.20 | 1.62K |
Scheduled
|
Dec 9
| ||
Form 4
|
∞
| 1.62K |
$39.65 | -$34,773.05 | 1.62K |
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AKCEA THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pacira BioSciences, Inc. (PCRX) Snapshot price: $13.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.24% | 2K |
$12.90 | $25,800.00 | 7.23K |
Aug 14
| |||
Form 4
|
∞
| 5.23K |
—
|
—
| 5.23K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IONIS PHARMACEUTICALS INC (IONS) Snapshot price: $46.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |